I have read the latest announcement a few times, and despite the 'unflatering' format, I remain uncertain where we actually stand.
Over the last couple of months we have had a large amount of things happen; from faulty announcement(s), a crashing share price, shareholder revolts, and unsavoury capital raisings. But besides all these, where do we stand in light of the latest results (i.e. the foundation of our company)???
If any of you with a better background and knowledge to decipher what the announcement means, please DO share. As far as I can see we did not achieve the targets set prior to the trials, but at the same time it does mention some benefits of patient improvements and safety of the product. Are we even able to get anything difinitive from whats been released?
If anyone can please help decipher BOTH the positives and negatives. This way we can maybe come to some form of educated guess as to what lies ahead.. Novo or No-Novo.
Thanks in advance
CBZ Price at posting:
21.5¢ Sentiment: None Disclosure: Held
